HCA
Hyperion Capital Advisors’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Hold |
2,130
| – | – | 0.29% | 34 |
|
|
2025
Q1 | $477K | Hold |
2,130
| – | – | 0.26% | 37 |
|
|
2024
Q4 | $698K | Sell |
2,130
-31
| -1% | -$10.2K | 0.36% | 29 |
|
|
2024
Q3 | $649K | Hold |
2,161
| – | – | 0.3% | 32 |
|
|
2024
Q2 | $712K | Hold |
2,161
| – | – | 0.33% | 30 |
|
|
2024
Q1 | $855K | Hold |
2,161
| – | – | 0.4% | 29 |
|
|
2023
Q4 | $761K | Sell |
2,161
-88
| -4% | -$31K | 0.41% | 28 |
|
|
2023
Q3 | $844K | Hold |
2,249
| – | – | 0.46% | 28 |
|
|
2023
Q2 | $860K | Hold |
2,249
| – | – | 0.47% | 26 |
|
|
2023
Q1 | $779K | Hold |
2,249
| – | – | 0.37% | 29 |
|
|
2022
Q4 | $529K | Hold |
2,249
| – | – | 0.26% | 34 |
|
|
2022
Q3 | $553K | Hold |
2,249
| – | – | 0.27% | 36 |
|
|
2022
Q2 | $680K | Hold |
2,249
| – | – | 0.32% | 33 |
|
|
2022
Q1 | $924K | Hold |
2,249
| – | – | 0.35% | 29 |
|
|
2021
Q4 | $1.06M | Sell |
2,249
-92
| -4% | -$43.2K | 0.24% | 28 |
|
|
2021
Q3 | $994K | Hold |
2,341
| – | – | 0.26% | 27 |
|
|
2021
Q2 | $841K | Sell |
2,341
-46
| -2% | -$16.5K | 0.24% | 26 |
|
|
2021
Q1 | $673K | Sell |
2,387
-34
| -1% | -$9.59K | 0.22% | 31 |
|
|
2020
Q4 | $686K | Sell |
2,421
-37
| -2% | -$10.5K | 0.27% | 27 |
|
|
2020
Q3 | $676K | Sell |
2,458
-184
| -7% | -$50.6K | 0.33% | 21 |
|
|
2020
Q2 | $600K | Sell |
2,642
-109
| -4% | -$24.8K | 0.35% | 22 |
|
|
2020
Q1 | $419K | Hold |
2,751
| – | – | 0.3% | 28 |
|
|
2019
Q4 | $414K | Buy |
+2,751
| New | +$414K | 0.22% | 27 |
|